BioSpace News Archive

Genetown

Innovation Pharmaceuticals Brilacidin Franchise Anchored in Three Clinical Indications — Oral Mucositis, Inflammatory Bowel Disease and Serious Skin Infections; Expands into Dermatologic Diseases

The company gave a business update today.

January 29, 2018
·
6 min read
BioMidwest

Sun Biopharma Announces Initiation of First-Line Combination Study of Sbp-101 With Gemcitabine and Nab-Paclitaxel in Patients With Pancreatic Cancer

It is anticipated that the first patient will be enrolled in early Q2 2018.

January 29, 2018
·
5 min read
Drug Development

Abeona Receives FDA Regenerative Medicine Advanced Therapy Designation for EB-101 Gene Therapy in Epidermolysis Bullosa

EB-101 is the Company’s gene-corrected autologous cell therapy product for patients with recessive dystrophic epidermolysis bullosa.

January 29, 2018
·
6 min read
Business

Ultragenyx Names Former Alexion Exec as New CMO

Most recently, Dr. Bedrosian was Senior Vice President and Chief Medical Officer at Alexion.

January 29, 2018
·
3 min read
Biotech Bay

Adamas Announces Closing of Its Public Offering of Common Stock, and Full Exercise of Underwriters’ Option to Purchase Additional Shares

The purchase of the 3,000,000 shares closed on January 26, 2018. The sale of the 450,000 shares is expected to close on January 30, 2018, subject to customary closing conditions.

January 29, 2018
·
2 min read
Drug Development

Bellerophon Therapeutics Announces Enrollment Exceeds 100 Patients in Phase III INOvation-1 Study Evaluating INOpulse for Treatment of Pulmonary Arterial Hypertension

The Company anticipates the readout of the interim analysis in mid-2018, and the availability of top-line data from the full study toward the end of 2018.

January 29, 2018
·
5 min read
Drug Development

China Oncology Focus Limited Receives Approval by Chinese Authorities to Begin Clinical Trials in Three Separate Cancer Indications Using Sorrento’s Anti-PD-L1 Monoclonal Antibody

The trials will be anticipated to use a 3+3 design with 5mg/kg, 10mg/kg and 15mg/kg dosing regimens. O

January 29, 2018
·
7 min read
BioCapital

Rexahn Pharmaceuticals Receives Notice of Allowance for A New U.S. Patent Covering the Use of RX-5902 (Supinoxin)

The allowed application will extend the patent protection for uses claimed under this patent until 2036.

January 29, 2018
·
6 min read
Policy

Pernix Announces Patent Litigation Settlement Agreement With Actavis Concerning Zohydro ER

The litigation has been pending in the U.S. District Court for the District of Delaware and resulted from Actavis’s submission of an ANDA to the FDA seeking approval to market a generic version of Zohydro ER.

January 29, 2018
·
4 min read
Business

Prime Therapeutics and Boehringer Ingelheim Enter Into Outcomes-Based Contract for Jardiance

As a PBM owned by 18 Blue Cross and Blue Shield plans, Prime is uniquely positioned to analyze both medical and pharmacy claims data to evaluate and manage total cost of care.

January 29, 2018
·
3 min read